StreetAccount Summary - Trading higher/lower: China mid-morning
StreetAccount Scorecard: Weekly performance of the FTSE China Index sectors (ending 1-Aug)
Hangzhou Tigermed Consulting to sell equity stake in LaNova Medicines for $34.1M (CNY 58.23, 0.00)
Hangzhou Tigermed Consulting upgraded to buy from sell at Citi
Powered by FactSet Research Systems Inc.